Mike Taylor is a software engineer by day, a palaeontologist by night, and an open-access advocate in his spare time. Among his achievements are the co-description and naming of two dinosaurs: Xenoposeidon (“alien earthquake god”) and Brontomerus (“thunder thighs”). With fellow palaeontologist Matt Wedel, he runs the blog Sauropod Vertebra Picture of the Week, a 50/50 blend of hardcore osteology and scholarly publishing discussion.


CC-BY (2.0) epSos.de.

It’s widely recognised that the established scholarly publishers skim an awful lot of money off the top of research budgets. The Big Four (Elsevier, Springer, Wiley, Informa) all have profit margins in the range 32–42%. For Elsevier alone, a 38.9% profit on revenue of £2126M (page 17 of their own 2013 annual report) represents £826M diverted away from research – a figure more than sixteen times the £50M that the Finch Report estimated as the annual cost of transition to an all-open-access ecosystem.

Elsevier representatives will point out in their defence that some open-access publishers have even higher profit-margins: for example Hindawi’s founder claimed in a 2012 interview a net profit of $3.3M on revenue of $6.3M for the first half of 2012 – a profit of 52.4%. Even PLOS, an avowedly non-profit organisation, runs at an operating surplus of 27% (expenses of $37M against revenue of $50.8M according to their 2013 report).

Can this be justified? I have three thoughts.

First, the emphasis on profit margins – that is, profit as a percentage of revenue – is misleading. Hindawi’s median APC is $600 (calculated from their listing). So a 52.4% profit on a typical paper represents $314 leaving academia and going into shareholders’ pockets; whereas 38.9% of a typical Elsevier paper, with an APC of $3000, is $1167. So when the Wellcome Trust funds publication in a hybrid OA Elsevier journal, it diverts nearly four times as much cash out of academia than when its authors use Hindawi.

Second, much depends on the destination of the profits. When Elsevier or Hindawi profit from publishing, that money is lost to academia. By contrast, PLOS’s operating surplus – $367 of the $1350 APC on a PLOS ONE paper – is ploughed back into their mission “to accelerate progress in science and medicine by leading a transformation in research communication”. The same obviously applies to society publishers such as the Royal Society itself.

Finally, and most important, what really matters is not how much profit a publisher makes, but simply how much they charge to publish. To funding agencies, the price of an APC is money that can’t be spent elsewhere, whether it goes to publisher profits or merely covers publisher costs. It’s better to pay a $400 APC of which $200 is profit than a $500 APC of which $150 is profit. APC funds can be more effectively used when the price of publishing goes down, and it really doesn’t matter much whether that is achieved by publishers cutting profits or cutting costs.

And this in the end is the conclusive argument against legacy publishers such as Elsevier: irrespective of what the profit margins are, the prices are simply too expensive. There is no legitimate need for the Wellcome Trust to continue spending an average of £1821 ($2730) on APCs, mostly with legacy publishers, when newer born-digital publishers can do an objectively better job for much less money.


This post was published in relation to our Future of Scholarly Scientific Communication events (#FSSC), bringing together stakeholders in a series of discussions on evolving and controversial areas in scholarly communication, looking at the impact of technology, the culture of science and how scientists might communicate in the future.

  • CAYdenberg

    “Objectively better job” is where old-school academiticians have a hard time. What are the metrics we can use to establish “objective quality” of the publication itself – not the impact factor of what they publish, but the measures of how good a publisher they actually are.

    • Mike Taylor

      I should have said more about what I consider “objectively better”. I’m talking about things like:

      * painlessness of submission system

      * speed of editorial handling

      * transparency of editorial handling, notifications, etc.

      * quality of reviewing

      * speed of production after acceptance

      * design of typesetting

      * functionality of website

      * deposit in PubMed Central, LOCKSS, etc.

      * provision of post-publication review facilities

      A journal like PeerJ, in my experience (see https://peerj.com/articles/36/) has been outstanding in all these respects. That’s for a paper that cost me and my co-author a total of $198 in membership fees (which approximates to an APC).

  • It’s spooky how similarly we were thinking, Mike. I was just getting ready to press the button on my own post: http://bazargan.org/we-should-applaud-higher-profits-not-lower-profits/ when I saw the tweet to this.

    I would be interested to see some details of how PLOS is spending the $37m. Does anyone have details? It’s a lot of money. ;-)